A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data
Article first published online: 19 JAN 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 230–235, January 2012
How to Cite
Carnahan, R. M. and Kee, V. R. (2012), A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data. Pharmacoepidem. Drug Safe., 21: 230–235. doi: 10.1002/pds.2325
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
- Food and Drug Administration. Grant Number: HHSF223200910006I
- 6Facilitating Cross-National Comparisons of Indicators for Patient Safety at the Health-System Level in the OECD Countries. OECD Health Technical Papers No. 19. http://www.oecd.org/dataoecd/24/48/40401929.pdf [accessed 30 August 2010]..
- 7Frequency and outcomes of blood products transfusion across procedures and clinical conditions warranting inpatient care: an analysis of the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample database. Am J Med Qual 2010; 25(4): 289–296., , , et al.
- 11Proposed changes to ICD-9-CM: transfusion associated adverse events. Presented September 17, 2009, at the ICD-9-CM Coordination and Maintenance Committee Meeting. http://www.cdc.gov/nchs/ppt/icd9/att1_Menis_Sep09.pdf [accessed 1 September 2010]..
- 12Centers for Disease Control and Prevention: National Healthcare Safety Network: Biovigilance Component. http://www.cdc.gov/nhsn/bio.html [accessed 6 September 2011].